<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)
November 17, 2000 (November 17, 2000)
OMNI NUTRACEUTICALS, INC.
--------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
UTAH 0-18160 87-046822
-------------------------------- ------------ ----------------------------
(STATE OR OTHER JURISDICTION (COMMISSION (IRS EMPLOYER
OF INCORPORATION) FILE NUMBER) IDENTIFICATION NO.)
5310 BEETHOVEN STREET
LOS ANGELES, CA 90066
--------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (310) 306-3636
N/A
(FORMER NAME AND FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
<PAGE>
OMNI NUTRACEUTICALS, INC.
TABLE OF CONTENTS
FOR
CURRENT REPORT ON FORM 8-K
Page no.
---------
Item 5. Other Events 1
Item 7. Exhibits
Signature
ITEM 5
OTHER EVENTS
On November 17, 2000, the Company announced that NASDAQ has notified the Company
that it will delist its stock from the NASDAQ National Market System, effective
today, November 17, 2000.
The reasons given by NASDAQ include:
The Company's delinquency in filing its amended Form 10-K for 1999, as reported
in a Form 8-K dated November 2, 2000 and a press release issued on October 17,
2000; and technical nonconformity with a certain NASDAQ rule related to certain
provisions of documents from a private placement recently completed by the
Company.
The Company has 15 days to appeal this decision, but such appeal does not act as
a stay of the decision.
The Company intends to appeal this decision by NASDAQ and take such other steps
as may be necessary to return to full compliance, including imminently filing
its amended 10-KSB/A and 10-Q/As. In the meantime, the stock will be available
for trading on the Pink Sheets. The press release is included herewith as an
Exhibit.
ITEM 7
EXHIBIT
10.28 Press Release (dated November 17, 2000).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
OMNI NUTRACEUTICALS, INC.
Date: November 17, 2000
By: /s/ KLEE IRWIN
------------------
Klee Irwin
1
